These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 1483553)
1. [Stomach adenocarcinomas: comparison between CA 19-9 and carcinoembryonic antigen for the diagnosis of recurrences after surgical treatment]. Ychou M; Tuszinski T; Pignon JP; Bidart JM; Bellet D; Bohuon C; Rougier P Gastroenterol Clin Biol; 1992; 16(11):848-52. PubMed ID: 1483553 [TBL] [Abstract][Full Text] [Related]
2. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Lai IR; Lee WJ; Huang MT; Lin HH Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection. Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced transient CEA and CA19-9 surges in patients with metastatic or recurrent gastric cancer. Kim HJ; Lee KW; Kim YJ; Oh DY; Kim JH; Im SA; Lee JS Acta Oncol; 2009; 48(3):385-90. PubMed ID: 18855156 [TBL] [Abstract][Full Text] [Related]
5. Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer. Li Y; Yang Y; Lu M; Shen L Hepatogastroenterology; 2011; 58(112):2166-70. PubMed ID: 22024091 [TBL] [Abstract][Full Text] [Related]
6. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA. Kodama I; Koufuji K; Kawabata S; Tetsu S; Tsuji Y; Takeda J; Kakegawa T Int Surg; 1995; 80(1):45-8. PubMed ID: 7657491 [TBL] [Abstract][Full Text] [Related]
7. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459 [TBL] [Abstract][Full Text] [Related]
8. [The role of tumor markers in diagnosing metastases of gastric cancer: preoperative diagnostics (part I)]. Kurygin AA; Maĭstrenko NA; Khrykov GN; Beliak NP Vestn Khir Im I I Grek; 2009; 168(4):16-9. PubMed ID: 19947409 [TBL] [Abstract][Full Text] [Related]
9. The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy. Kim DH; Oh SJ; Oh CA; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S J Surg Oncol; 2011 Nov; 104(6):585-91. PubMed ID: 21695697 [TBL] [Abstract][Full Text] [Related]
10. Receiver operating characteristic (ROC) curve analysis of the tumor markers CEA, CA 19-9 and CA 72-4 in gastric cancer. Fernández-Fernández L; Tejero E; Tieso A; Rabadán L; Munoz M; Santos I Int Surg; 1996; 81(4):400-2. PubMed ID: 9127805 [TBL] [Abstract][Full Text] [Related]
11. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Takahashi Y; Takeuchi T; Sakamoto J; Touge T; Mai M; Ohkura H; Kodaira S; Okajima K; Nakazato H; Gastric Cancer; 2003; 6(3):142-5. PubMed ID: 14520526 [TBL] [Abstract][Full Text] [Related]
12. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733 [TBL] [Abstract][Full Text] [Related]
13. [Adenocarcinoma of the bladder producing carcinoembryonic antigen and carbohydrate antigen 19-9: report of a case]. Iwaki H; Omatsu S; Konishi T; Moritani S Hinyokika Kiyo; 1997 May; 43(5):355-8. PubMed ID: 9208321 [TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen level is related to tumor invasion into the serosa of the stomach: study on 166 cases and suggestion for new therapy. Zhang YH; Li Y; Chen C; Peng CW Hepatogastroenterology; 2009; 56(96):1750-4. PubMed ID: 20214231 [TBL] [Abstract][Full Text] [Related]
15. [CA 15-3 associated with CEA and TPA in the follow-up of breast carcinoma]. Maffei S; Rudoni M; Antonini G; Sacchetti G; Krengli M Minerva Med; 1990 Nov; 81(11):759-63. PubMed ID: 2255409 [TBL] [Abstract][Full Text] [Related]
16. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases. Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469 [TBL] [Abstract][Full Text] [Related]
17. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer. Carpelan-Holmström MA; Haglund CH; Järvinen HJ; Roberts PJ Anticancer Res; 1996; 16(2):981-6. PubMed ID: 8687164 [TBL] [Abstract][Full Text] [Related]
18. [Significance of CA72-4 as a follow up of recurrent gastric cancer--comparison with CEA and CA19-9]. Takahashi Y; Mai M Gan To Kagaku Ryoho; 1992 Apr; 19(4):515-8. PubMed ID: 1558402 [TBL] [Abstract][Full Text] [Related]
19. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244 [TBL] [Abstract][Full Text] [Related]
20. [Tumor markers in the upper intestinal tract--stomach and pancreas]. Pointner R; Conrad F; Schwab G Wien Klin Wochenschr; 1989 Jul; 101(14):482-4. PubMed ID: 2773485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]